Publicaciones (34) Publicaciones de JOSEBA BIDAURRAZAGA VAN-DIERDONCK

2024

  1. Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study

    PharmacoEconomics, Vol. 42, Núm. 2, pp. 219-229

  2. Modeling spillover dynamics: understanding emerging pathogens of public health concern

    Scientific reports, Vol. 14, Núm. 1, pp. 9823

2023

  1. The effect of mixed vaccination rollout strategy: A modelling study

    Infectious Disease Modelling, Vol. 8, Núm. 2, pp. 318-340

2022

  1. Changes in Social and Clinical Determinants of COVID-19 Outcomes Achieved by the Vaccination Program: A Nationwide Cohort Study

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 19

2021

  1. An ensemble-based feature selection framework to select risk factors of childhood obesity for policy decision making

    BMC Medical Informatics and Decision Making, Vol. 21, Núm. 1

  2. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study

    Digestive and Liver Disease, Vol. 53, Núm. 5, pp. 639-645

2020

  1. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study

    European Journal of Surgical Oncology, Vol. 46, Núm. 6, pp. 1151-1159

  2. Modelling COVID 19 in the Basque Country from introduction to control measure response

    Scientific Reports, Vol. 10, Núm. 1

  3. Reproduction ratio and growth rates: Measures for an unfolding pandemic

    PLoS ONE, Vol. 15, Núm. 7 July

2018

  1. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 201-211

2017

  1. Cancer incidence in Spain, 2015

    Clinical and Translational Oncology, Vol. 19, Núm. 7, pp. 799-825

  2. Data quality in rare cancers registraton: The report of the RARECARE data quality study

    Tumori, Vol. 103, Núm. 1, pp. 22-32

  3. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  4. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  5. Geographical variability in survival of European children with central nervous system tumours

    European Journal of Cancer, Vol. 82, pp. 137-148

  6. Population-based colorectal cancer screening programmes using a faecal immunochemical test: Should faecal haemoglobin cut-offs differ by age and sex?

    BMC Cancer, Vol. 17, Núm. 1

  7. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5

    European Journal of Cancer, Vol. 77, pp. 140-152

  8. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 405-413

  9. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 396-404

  10. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

    The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217